TWiV 1028: Asymptomatic SARS-CoV-2 infection and T cells
TWiV reviews approvals of the first gene therapy for severe hemophilia A in adults and a monoclonal antibody to prevent RSV respiratory disease in babies and toddlers, and a common allele of HLA that mediates asymptomatic SARS-CoV-2 infection through pre-existing T cell immunity due to previous exposure to common cold coronaviruses. Hosts: Vincent Racaniello, Dickson Despommier, Alan Dove, Kathy Spindler, and Brianne Barker Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode MicrobeTV Discord Server First gene therapy for hemophilia A approved (FDA) Lux...
Source: This Week in Virology - MP3 Edition - July 23, 2023 Category: Virology Authors: Vincent Racaniello Source Type: podcasts
Guy Young, MD - Defining the Role of Extended Half-Life Replacement Clotting Factors in the Modern Management of Hemophilia A
Defining the Role of Extended Half-Life Replacement Clotting Factors in the Modern Management of Hemophilia A (Source: PeerView CME/CE Audio Podcast - Oncology)
Source: PeerView CME/CE Audio Podcast - Oncology - March 1, 2019 Category: Cancer & Oncology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts
Mark T. Reding, MD - Treatment Innovation in hemophilia A: Integrating Extended Half-Life Replacement Clotting Factors Into Clinical Practice
Treatment Innovation in hemophilia A: Integrating Extended Half-Life Replacement Clotting Factors Into Clinical Practice (Source: PeerView CME/CE Audio Podcast - Oncology)
Source: PeerView CME/CE Audio Podcast - Oncology - November 12, 2018 Category: Cancer & Oncology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts
Mark T. Reding, MD - Monitoring Hemostasis in Hemophilia A in an Era of Approved and Emerging Extended Half-Life Factor VIII Therapies: A Visual Guide to Using the Optimal Coagulation Assay and Reagents
Monitoring Hemostasis in Hemophilia A in an Era of Approved and Emerging Extended Half-Life Factor VIII Therapies: A Visual Guide to Using the Optimal Coagulation Assay and Reagents (Source: PeerView CME/CE Audio Podcast - Oncology)
Source: PeerView CME/CE Audio Podcast - Oncology - March 19, 2018 Category: Cancer & Oncology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts
Guy Young, MD - Illuminating the Role of Shared Decision-Making as the Hemophilia A Management Landscape Continues to Evolve: Progress in Practice
Illuminating the Role of Shared Decision-Making as the Hemophilia A Management Landscape Continues to Evolve: Progress in Practice (Source: PeerView CME/CE Audio Podcast - Pulmonology)
Source: PeerView CME/CE Audio Podcast - Pulmonology - December 29, 2017 Category: Respiratory Medicine Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts
Guy Young, MD - Assessing Recent Advances in Hemophilia A Management: What Are the Key Learnings From Berlin?
Assessing Recent Advances in Hemophilia A Management: What Are the Key Learnings From Berlin? (Source: PeerView CME/CE Audio Podcast - Oncology)
Source: PeerView CME/CE Audio Podcast - Oncology - September 18, 2017 Category: Cancer & Oncology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts
Impact to Clinical Practice: Linear and Logistic Regression Models Hemophilia from Pain
Anne Neff, MD of Cleveland Clinic talks about how new research in hemophilia will impact clinical practitioners at the 58th ASH Annual Meeting in San Diego, CA.
Author: ASHReport
Added: 12/16/2016 (Source: Oncology Tube)
Source: Oncology Tube - December 16, 2016 Category: Cancer & Oncology Source Type: podcasts
Preventing Hemophilia
Anne Neff, MD of Cleveland Clinic discusses how to prevent hemophilia from pain and functional impairment at the 58th ASH Annual Meeting in San Diego, CA.
Author: ASHReport
Added: 12/16/2016 (Source: Oncology Tube)
Source: Oncology Tube - December 16, 2016 Category: Cancer & Oncology Source Type: podcasts
Linear and Logistic Regression Models in US Adults with Hemophilia
Anne Neff, MD of Cleveland Clinic, gives an overview of her abstract, Linear and Logistic Regression Models of Patient-Reported Outcomes and Patient Characteristics in US Adults with Hemophilia from t...
Author: ASHReport
Added: 12/16/2016 (Source: Oncology Tube)
Source: Oncology Tube - December 16, 2016 Category: Cancer & Oncology Source Type: podcasts
Gene Therapy Development in Hemophilia
Katherine A. High, MD of Spark Therapeutics, presents a press briefing on Spk-9001: Adeno-Associated Virus Mediated Gene Transfer for Hemophilia B Achieves Sustained Mean Factor IX Activity Levels of ...
Author: ASHReport
Added: 12/07/2016 (Source: Oncology Tube)
Source: Oncology Tube - December 7, 2016 Category: Cancer & Oncology Source Type: podcasts
Targeted Factor VIII Delivery
Caroline E. Hansen, BS of Georgia Institute of Technology presents Leveraging the Contractile Force of Platelets for Targeted Factor VIII Delivery in Hemophilia with Inhibitors at the 58th ASH Annual ...
Author: ASHReport
Added: 12/07/2016 (Source: Oncology Tube)
Source: Oncology Tube - December 7, 2016 Category: Cancer & Oncology Source Type: podcasts
Guy Young, MD - An Up-to-Date Review of New Data on Modified Replacement Clotting Factors in Hemophilia Management: What Have We Learned in 2016 Thus Far?
An Up-to-Date Review of New Data on Modified Replacement Clotting Factors in Hemophilia Management: What Have We Learned in 2016 Thus Far? (Source: PeerView CME/CE Audio Podcast - Oncology)
Source: PeerView CME/CE Audio Podcast - Oncology - September 26, 2016 Category: Cancer & Oncology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts
Highlights from EHA 2016 press briefings: Nivolumab, SGN-CD33A and hemophilia
Anton Hagenbeek, MD, PhD from University of Amsterdam, Netherlands provides a summary of the press briefings held at the European Hematology Association (EHA) 2016 Annual Congress in Copenhagen, Denma...
Author: VJHemOnc
Added: 08/03/2016 (Source: Oncology Tube)
Source: Oncology Tube - August 3, 2016 Category: Cancer & Oncology Source Type: podcasts
Courtney D. Thornburg, MD, MS - Improving Replacement Clotting Factor Prophylaxis in a New Era of Hemophilia Management
Improving Replacement Clotting Factor Prophylaxis in a New Era of Hemophilia Management (Source: PeerView CME/CE Audio Podcast - Oncology)
Source: PeerView CME/CE Audio Podcast - Oncology - April 18, 2016 Category: Cancer & Oncology Authors: PVI, PeerView Institute for Medical Education Tags: Science, Medicine Source Type: podcasts
